483
Daniel P Friedmann MDFDA 483 - Daniel P Friedmann MD - January 16, 2020
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
The FDA inspected Daniel P Friedmann MD, a clinical investigator in Austin, TX, and observed a significant deviation from the investigational plan. The firm failed to perform required blinded evaluations for multiple subjects at various time points, including the primary endpoint, during a clinical study. This indicates a serious issue with protocol adherence and data integrity.
Open in Dashboard
ID · 078551bb-73ce-44e7-8c81-91a8f4ae9e01